Ingrid Ibarra
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- RNA Interference and Gene Delivery
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- Advanced biosensing and bioanalysis techniques
Papers in
-
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 2
- Oncology 3
- Cancer Cells and Metastasis 2
- Pancreatic and Hepatic Oncology Research 1
- Co-authors
- Gregory James Hannon (3 shared papers)Michael T. Hemann (1 shared paper)Ross A. Dickins (1 shared paper)Scott Lowe (1 shared paper)David R. Simpson (1 shared paper)Jack T. Zilfou (1 shared paper)Amber N. Heath (1 shared paper)Shang Li (1 shared paper)
- Journals
- Oncotarget (1 paper)Nature Genetics (1 paper)PLoS Genetics (1 paper)Cancer Research (1 paper)Nature Communications (1 paper)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Ingrid Ibarra
6 papers receiving 726 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 294
- Molecular Biology 525
- Oncology 161
- Endocrine and Autonomic Systems 24
- Immunology 74
Countries citing papers authored by Ingrid Ibarra
This map shows the geographic impact of Ingrid Ibarra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Ibarra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Ibarra more than expected).
Fields of papers citing papers by Ingrid Ibarra
This network shows the impact of papers produced by Ingrid Ibarra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Ibarra. The network helps show where Ingrid Ibarra may publish in the future.
Co-authors
The 25 scholars most cited alongside Ingrid Ibarra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 432 | |
| 2 | 2012 | 146 | |
| 3 | 2014 | 58 | |
| 4 | 2015 | 49 | |
| 5 | 2015 | 43 | |
| 6 | 2021 | 12 |
About Ingrid Ibarra
Ingrid Ibarra is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Immunology and Endocrine and Autonomic Systems, having authored 6 papers that have together received 740 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Cancer Mechanisms and Therapy (2 papers), Cancer-related molecular mechanisms research (2 papers), Cancer Cells and Metastasis (2 papers), Immune Cell Function and Interaction (1 paper), Hematopoietic Stem Cell Transplantation (1 paper), Pancreatic and Hepatic Oncology Research (1 paper) and Mechanisms of cancer metastasis (1 paper). The work is most often cited by research in Cancer Research (294 citations), Molecular Biology (525 citations), Oncology (161 citations), Endocrine and Autonomic Systems (24 citations) and Immunology (74 citations). Ingrid Ibarra has collaborated with scholars based in United States, China and France. Frequent co-authors include Gregory James Hannon, Michael T. Hemann, Ross A. Dickins, Scott Lowe, David R. Simpson, Jack T. Zilfou, Amber N. Heath, Shang Li, Sean McDermott and Shivani H. Patel. Their work appears in journals such as Oncotarget, Nature Genetics, PLoS Genetics, Cancer Research and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.